Doctor profile · Federal record

Dr. Jay Sidloski, DO

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Medical Oncology Physician · Elyria, OH

  • NPI 1912950502
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 29 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
41201 Schadden RD, Suite 2
Elyria, OH 440352220
(440) 324-0401
fax (440) 324-0405
Mailing address
Po Box 749495
Atlanta, GA 303749495

Credentials & registration

NPPES · NUCC
NPI registered
May 2006 — 20 yrs on file
Profile last updated
January 10, 2023
Year of graduation
1997 — 29 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Ohio #007091
Medicaid
OH #2469001

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1912950502. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
93,707
Distinct HCPCS
10
Medicare allowed
$1,219,401
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 39,270 40 $0
J9271 Injection, pembrolizumab, 1 mg 15,600 14 $54
J9263 Injection, oxaliplatin, 0.5 mg 12,300 14 $0
J0185 Injection, aprepitant, 1 mg 11,830 30 $2
J0897 Injection, denosumab, 1 mg 3,240 16 $23
J1100 Injection, dexamethasone sodium phosphate, 1 mg 2,302 47 $0
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 1,572 568 $8
J2469 Injection, palonosetron hcl, 25 mcg 1,250 35 $1
99213 Established patient office or other outpatient visit, 20-29 minutes 872 491 $86
J0640 Injection, leucovorin calcium, per 50 mg 598 13 $4

In context: peer comparison

Among 3 peers in Elyria Hematology & Oncology Physician, average services per provider: 1,928. This provider delivers 49× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,419
Transactions
63
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 8 $230.76
Pfizer INC. 13 $173.72
Regeneron Healthcare Solutions, INC. 4 $167.28
Takeda Pharmaceuticals U.S.A., INC. 5 $122.11
Sirtex Medical INC 1 $118.38
Novartis Pharmaceuticals Corporation 4 $115.33
Karyopharm Therapeutics INC. 1 $101.12
Celgene Corporation 6 $97.64
AstraZeneca Pharmaceuticals Lp 4 $83.99
E.R. Squibb & Sons, L.L.C. 4 $78.65
Eisai INC. 3 $68.04
Merck Sharp & Dohme LLC 3 $64.12
Janssen Biotech, INC. 3 $59.89
Ipsen Biopharmaceuticals, INC 2 $51.75
Daiichi Sankyo INC. 2 $50.26

By nature of payment

Food and Beverage
$2,402
Education
$17

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,487
Patients
297
Total drug cost
$2,721,247
Drug Type Claims Patients Total cost
Anastrozole Generic 464 113 $13,002
Xarelto (Rivaroxaban) Brand 241 48 $232,639
Eliquis (Apixaban) Brand 141 35 $114,316
Dexamethasone Generic 112 29 $1,778
Revlimid (Lenalidomide) Brand 93 12 $1,351,076
Acyclovir Generic 65 12 $598
Imbruvica (Ibrutinib) Brand 58 0 $807,357
Letrozole Generic 47 18 $3,254
Prednisone Generic 43 17 $336
Hydroxyurea Generic 41 0 $803

Frequently asked questions

Auto-generated from federal data
What is Dr. Jay Sidloski's medical specialty?
Dr. Jay Sidloski practices Hematology & Oncology Physician in Elyria, OH.
Where does Dr. Jay Sidloski practice?
Dr. Jay Sidloski practices at 41201 Schadden RD, Elyria, OH 440352220. Office phone: 4403240401.
What is Dr. Jay Sidloski's NPI?
Dr. Jay Sidloski's National Provider Identifier (NPI) is 1912950502, issued by NPPES.
Does Dr. Jay Sidloski accept Medicare assignment?
Yes. Dr. Jay Sidloski accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jay Sidloski commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, oxaliplatin, 0.5 mg (HCPCS J9263). Source: CMS Medicare Physician & Other Practitioners file.